Abbott Issues Updated 2021 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Abbott Laboratories (ABT) Falls After Cutting Full-Year Outlook on Lower Demand for Covid-19 Tests
June 1, 2021 10:56 AM EDTShares of Abbott Laboratories (NYSE: ABT) are down 6.5% in todays trading session after the company issued an updated 2021 outlook to reflect lower demand from its diagnostic unit.
The company cited significantly lower recent and projected COVID-19 diagnostic testing demand amid an accelerated vaccination activity.
Hence, the company now expects full-year 2021 EPS of $2.75 to $2.95 and full-year adjusted EPS of $4.30 to $4.50, below the consensus of... More
